Skip to main content
RPID
NASDAQ Industrial Applications And Services

Rapid Micro Biosystems Reports Q1 Results with Strong Revenue Growth, High Cash Burn, Reaffirms 2026 Guidance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$2.48
Mkt Cap
$113.502M
52W Low
$2.01
52W High
$4.94
52W Position info
23% above low
Off High info
50% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

RPID sits 23% above its 52-week low of $2.01.

Summary

Rapid Micro Biosystems announced Q1 2026 results showing revenue growth and reaffirmed 2026 guidance, but reported a substantial increase in net loss and a significant reduction in cash, raising critical liquidity concerns.


Key Events · Earnings and Guidance · RPID

  • Q1 2026 Revenue Growth

    Total revenue increased 11.1% year-over-year to $8.0 million, with product revenue up 36% and recurring revenue up 28%.

  • Increased Net Loss

    Net loss widened to $14.3 million ($0.31 per share) in Q1 2026, compared to $11.3 million ($0.26 per share) in Q1 2025.

  • Significant Cash Burn

    Cash, cash equivalents, and short-term investments decreased by $15.35 million, from $38.6 million at year-end 2025 to $23 million as of March 31, 2026, indicating a rapid depletion of liquidity.

  • 2026 Guidance Reaffirmed

    The company reaffirmed its full-year 2026 revenue guidance of $37.0 million to $41.0 million and gross margin guidance of approximately 20%.


Analysis · RPID · Industrial Applications And Services

Rapid Micro Biosystems reported strong Q1 2026 revenue growth, driven by increased product sales and recurring revenue, and reaffirmed its full-year 2026 guidance. However, the company experienced a significant cash burn, with cash and equivalents dropping from $38.6 million to $23 million in one quarter. This rapid depletion of liquidity raises serious concerns about the company's cash runway, especially in light of the previously stated 12-month liquidity runway from the March 12, 2026 10-K filing. The net loss also widened.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, RPID was trading at $2.48 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $113.5M. The 52-week trading range was $2.01 to $4.94. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

RPID - Latest Insights

RPID
Nov 19, 2026, 5:10 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.7388
Real-time Price: $0.7388 info
Change: $0 (0%) info
Market Cap: $36.882M info
RPID
Nov 16, 2026, 4:14 PM EST
Filing Type: 8-K
Importance Score:
10
Price at Filing: $0.7326
Real-time Price: $0.7388 info
Change: +$0.0062 (+0.85%) info
Market Cap: $36.882M info
RPID
Nov 16, 2026, 10:17 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.7345
Real-time Price: $0.7388 info
Change: +$0.0043 (+0.59%) info
Market Cap: $36.882M info
RPID
Nov 16, 2026, 9:26 AM EST
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $0.675
Real-time Price: $0.7388 info
Change: +$0.0638 (+9%) info
Market Cap: $36.882M info
RPID
Aug 07, 2026, 7:33 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $2.08
Real-time Price: $0.7388 info
Change: -$1.34 (-64%) info
Market Cap: $36.882M info